Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118299 · ClinicalTrials.gov registry record · NA
AMPLATZER Cardiac Plug Clinical Trial
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT01118299 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 97 participants.
The verdict
NCT01118299, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and effectiveness of the ACP in subjects with nonvalvular atrial fibrillation by demonstrating that the device is non-inferior to optimal medical therapy (OMT) with respect to the primary effectiveness endpoint and superior to OMT with respect to primary safety endpoint.
Interventions
- DEVICE AMPLATZER Cardiac Plug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2010-04-26 |
| Est. Completion | 2018-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01118299
The ClinicalTrials.gov registry entry for NCT01118299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AMPLATZER Cardiac Plug is the first listed.
NCT01118299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01118299 about?
NCT01118299 is a clinical study titled "AMPLATZER Cardiac Plug Clinical Trial". The objective of this study is to evaluate the safety and effectiveness of the ACP in subjects with nonvalvular atrial fibrillation by demonstrating that the device is non-inferior to optimal medical therapy (OMT) with respect to the primary effectiveness endpoint and superior to OMT with respect to...
What is the current status of trial NCT01118299?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2010-04-26. Estimated completion is 2018-12-06.
What interventions are being tested in trial NCT01118299?
The interventions under investigation include: AMPLATZER Cardiac Plug (DEVICE).
Who is sponsoring clinical trial NCT01118299?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.